Christine J. Chung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Christine J. Chung has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- James M. McCabe
Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington
4 shared publications Barbara A. Danek
University of Washington Medical Center, Seattle, Washington, USA
3 shared publications- David Elison
Division of Cardiology, University of Washington Medical Center, Seattle, Washington, USA
3 shared publications - Gregory J. Condos
Department of Cardiology, Naval Medical Center, San Diego, California
2 shared publications Angela M. Lowenstern
Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, USA https://twitter.com/CJChungMD
1 shared publicationBryce V. Johnson
Division of Cardiovascular Medicine, Department of Medicine, University of Washington, Seattle, Washington
1 shared publication
Latest Publications
- 23 September 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (18) , 2283-2284
Anchoring an Embolized SAPIEN Valve Using an Open-Cell Stent in the Innominate Artery
- 23 September 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (18) , 2283-2284
Anchoring an Embolized SAPIEN Valve Using an Open-Cell Stent in the Innominate Artery
- Open Access
- 18 March 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (3) , 102564
Randomized Trial of Shortened Supine Bedrest Following Transfemoral Transcatheter Aortic Valve Replacement
- 18 March 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (3) , 102564
Open AccessRandomized Trial of Shortened Supine Bedrest Following Transfemoral Transcatheter Aortic Valve Replacement
- Open Access
- 1 November 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 17 (11) , e014224
Transcatheter Mitral Valve Replacement Using Annular Reduction by Cinching With TEER in the Commissure (ARCTIC)
BACKGROUND: Mitral annular calcification with valve dysfunction remains a challenging syndrome. Operative risk is high, and available transcatheter therapies are limited. METHODS: This study describes our initial experience with a novel procedure to address large mitral annuli when no surgical or trial-based transcatheter mitral valve replacement device is available. The rationale was to shorten the intercommissural distance using commissural mitral transcatheter edge-to-edge repair (TEER) followed by valve-in-mitral annular calcification transcatheter mitral valve replacement with a balloon-expandable aortic valve platform. Patients with long intercommissural distances and large mitral annulus areas were selected based on a high perceived risk of transcatheter valve embolization. Patients underwent mitral TEER with MitraClip in a commissural position, followed immediately by transseptal transcatheter mitral valve replacement with a 29 mm SAPIEN 3 valve. RESULTS: Thirteen patients were included. Median intercommissural distance and annular area were 39.1 mm and 930 mm 2 , respectively. Commissural mitral TEER was successful in all patients with no instances of single leaflet detachment. In 10 of 13 instances, an NTW device size was used. In 12 of 13 patients, valve implantation was successful, including 1 case that required a second valve for atrial positioning of the first valve. In 1 case, frank valve embolization into the left atrium occurred. Among the 12 successful cases, paravalvular leak was 1+ or less, and there were no instances of paravalvular leak adjacent to the TEER device. CONCLUSIONS: In patients with large annuli and sufficient annular calcium, a hybrid mitral TEER and valve replacement with the SAPIEN platform can be successfully used to facilitate transcatheter mitral valve replacement.
- 1 November 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 17 (11) , e014224
Open AccessTranscatheter Mitral Valve Replacement Using Annular Reduction by Cinching With TEER in the Commissure (ARCTIC)
BACKGROUND: Mitral annular calcification with valve dysfunction remains a challenging syndrome. Operative risk is high, and available transcatheter therapies are limited. METHODS: This study describes our initial experience with a novel procedure to address large mitral annuli when no surgical or trial-based transcatheter mitral valve replacement device is available. The rationale was to shorten the intercommissural distance using commissural mitral transcatheter edge-to-edge repair (TEER) followed by valve-in-mitral annular calcification transcatheter mitral valve replacement with a balloon-expandable aortic valve platform. Patients with long intercommissural distances and large mitral annulus areas were selected based on a high perceived risk of transcatheter valve embolization. Patients underwent mitral TEER with MitraClip in a commissural position, followed immediately by transseptal transcatheter mitral valve replacement with a 29 mm SAPIEN 3 valve. RESULTS: Thirteen patients were included. Median intercommissural distance and annular area were 39.1 mm and 930 mm 2 , respectively. Commissural mitral TEER was successful in all patients with no instances of single leaflet detachment. In 10 of 13 instances, an NTW device size was used. In 12 of 13 patients, valve implantation was successful, including 1 case that required a second valve for atrial positioning of the first valve. In 1 case, frank valve embolization into the left atrium occurred. Among the 12 successful cases, paravalvular leak was 1+ or less, and there were no instances of paravalvular leak adjacent to the TEER device. CONCLUSIONS: In patients with large annuli and sufficient annular calcium, a hybrid mitral TEER and valve replacement with the SAPIEN platform can be successfully used to facilitate transcatheter mitral valve replacement.
- 1 October 2024
- Published by Elsevier in Interventional Cardiology Clinics
- Vol. 14 (1) , 127-136
Approach and Effects of Percutaneous Mitral Valve Repair in Women
- 1 October 2024
- Published by Elsevier in Interventional Cardiology Clinics
- Vol. 14 (1) , 127-136
Approach and Effects of Percutaneous Mitral Valve Repair in Women
- Open Access
- 14 August 2024
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 3 (9) , 102237
A Novel Protocol for Contrast-Free Transcatheter Aortic Valve Replacement Evaluation and Implantation
- 14 August 2024
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 3 (9) , 102237
Open AccessA Novel Protocol for Contrast-Free Transcatheter Aortic Valve Replacement Evaluation and Implantation
- Open Access
- 22 August 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 3 (2) , 101122
Danger, Danger, High Output
- 22 August 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 3 (2) , 101122
Open AccessDanger, Danger, High Output
- Open Access
- 9 March 2023
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 44 (15) , 1340-1342
Prevention and management of paravalvular regurgitation after transcatheter aortic valve implantation
Christine J Chung, MD, Catherine M Otto, MD; Prevention and management of paravalvular regurgitation after transcatheter aortic valve implantation, European Hea
- 9 March 2023
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 44 (15) , 1340-1342
Open AccessPrevention and management of paravalvular regurgitation after transcatheter aortic valve implantation
Christine J Chung, MD, Catherine M Otto, MD; Prevention and management of paravalvular regurgitation after transcatheter aortic valve implantation, European Hea